Wiggins Mark C

Avg. Two Year Performance

No purchase track record
20% Avg. Sale Return
10% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return16%30%(1%)0%0%
Purchase Success Rate2 of 42 of 41 of 40 of 40 of 4
Average Sale Return2%< 1%< 1%13%20%
Sale Success Rate9 of 208 of 208 of 2012 of 2012 of 20
Drugs » Biotechnology

Chief Business Officer:

Holdings: 13.7K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

EVP Corp. and Bus. Dev.:

Holdings: 22.78K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--